As our meta-analysis results were based on a combination of patient and lesion segments, there are very few research studies on 68Ga-PSMA PET/CT based on the lesion fragments of prostate cancer (10, 12, 15), and we only included them in the subgroup analysis instead of studying them separately. The gene discussed is FOLH1; the disease is prostate cancer.